Published in
Wiley, Alimentary Pharmacology and Therapeutics, 8(52), p. 1353-1365, 2020
DOI: 10.1111/apt.16060
Links
Tools
Long-term safety of vedolizumab for inflammatory bowel disease
Journal article published in 2020 by
Edward V. Loftus 
,
Brian G. Feagan ,
Remo Panaccione ,
Jean-Frédéric Colombel ,
William J. Sandborn ,
Bruce E. Sands ,
Silvio Danese ,
Geert D’Haens ,
David T. Rubin ,
Ira Shafran,
Andrejus Parfionovas,
Raquel Rogers,
Richard A. Lirio ,
Séverine Vermeire
,
Brian G. Feagan ,
Remo Panaccione ,
Jean-Frédéric Colombel ,
William J. Sandborn ,
Bruce E. Sands ,
Silvio Danese ,
Geert D’Haens ,
David T. Rubin ,
Ira Shafran,
Andrejus Parfionovas,
Raquel Rogers,
Richard A. Lirio ,
Séverine Vermeire
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 